Ameritas Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Ameritas Advisory Services's DGX Position: Q3 2026 in Review
Ameritas Advisory Services increased its Quest Diagnostics (DGX) stake by 0.47% in Q3 2026, buying an estimated $231 and bringing the position to 212 shares worth $49.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1271.
Ameritas Advisory Services first reported a position in DGX in Q1 2023 and has held it in 5 quarters since. The position peaked at $71.3K in Q1 2023. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Ameritas Advisory Services held 212 shares of Quest Diagnostics worth $49.4K as of Q3 2026.
- Ameritas Advisory Services bought 1 Quest Diagnostics share in Q3 2026, an estimated $231.
- Quest Diagnostics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q3 2026, its #1271 holding.
- Ameritas Advisory Services first reported a position in Quest Diagnostics in Q1 2023 and has held it in 5 quarters since.
- Ameritas Advisory Services's Quest Diagnostics position peaked at $71.3K in Q1 2023.
- 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Ameritas Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.